Literature DB >> 18640726

Characterisation of soluble murine CD137 and its association with systemic lupus.

Zhe Shao1, Feng Sun, Dow Rhoon Koh, Herbert Schwarz.   

Abstract

CD137 is a member of the tumor necrosis factor receptor family, and is involved in the regulation of activation, proliferation, differentiation and apoptosis of T cells, B cells, monocytes, dendritic cells, natural killer cells and granulocytes. Here report that soluble forms of murine CD137 (sCD137) are generated by differential splicing and are released by activated T cells. Levels of sCD137 correlate with cell activation and the extent of cell death but not with cellular proliferation. While CD8+ T cells express significantly more cell surface CD137 than CD4+ T cells, both T cell subsets express similar levels of sCD137, resulting a twofold increased ratio of soluble to cell surface CD137 for CD4+ T cells. sCD137 exists as a trimer and a higher order multimer, can bind to CD137 ligand, and inhibits secretion of IL-10 and IL-12. sCD137 is present in sera of mice with autoimmune disease but is undetectable in sera of healthy mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18640726     DOI: 10.1016/j.molimm.2008.05.028

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  13 in total

1.  Tumor necrosis factor receptor subfamily 9 (Tnfrsf9) gene is expressed in distinct cell populations in mouse uterus and conceptus during implantation period of pregnancy.

Authors:  Kirsten Eckstrum; Brent M Bany
Journal:  Cell Tissue Res       Date:  2011-05-12       Impact factor: 5.249

Review 2.  CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses.

Authors:  Bhushan Dharmadhikari; Meihui Wu; Nur Sharalyn Abdullah; Sakthi Rajendran; Nur Diana Ishak; Emily Nickles; Zulkarnain Harfuddin; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2015-11-11       Impact factor: 8.110

3.  CD137 signaling in Hodgkin and Reed-Sternberg cell lines induces IL-13 secretion, immune deviation and enhanced growth.

Authors:  Sakthi Rajendran; Weng Tong Ho; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2016-04-29       Impact factor: 8.110

4.  The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.

Authors:  Kritika Kachapati; David E Adams; Yuehong Wu; Charles A Steward; Daniel B Rainbow; Linda S Wicker; Robert S Mittler; William M Ridgway
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

5.  Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism.

Authors:  Sara Labiano; Asis Palazón; Elixabet Bolaños; Arantza Azpilikueta; Alfonso R Sánchez-Paulete; Aizea Morales-Kastresana; Jose I Quetglas; José L Perez-Gracia; Alfonso Gúrpide; Maria Rodriguez-Ruiz; M Angela Aznar; Maria Jure-Kunkel; Pedro Berraondo; Ignacio Melero
Journal:  Oncoimmunology       Date:  2015-06-24       Impact factor: 8.110

6.  Species difference of CD137 ligand signaling in human and murine monocytes.

Authors:  Qianqiao Tang; Dongsheng Jiang; Zhe Shao; Julia M Martínez Gómez; Herbert Schwarz
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

7.  Destroy, what destroys you.

Authors:  Khang Luu; Emily Nickles; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2019-11-03       Impact factor: 8.110

8.  Elevated soluble 4-1BB is associated with serum markers of hepatitis B virus in patients with chronic hepatitis B.

Authors:  Meng-Ru Zhan; Xiu-Zhu Gao; Chang Wang; Fei Peng; Xiao-Mei Wang; Hong-Qin Xu; Jun-Qi Niu
Journal:  World J Clin Cases       Date:  2021-03-06       Impact factor: 1.337

9.  Ectopic CD137 expression facilitates the escape of Hodgkin and Reed-Sternberg cells from immunosurveillance.

Authors:  Wan Lu Pang; Weng Tong Ho; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2013-04-01       Impact factor: 8.110

Review 10.  The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus.

Authors:  Anselm Mak; Herbert Schwarz
Journal:  Cells       Date:  2019-09-06       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.